世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

職業用医薬品市場:用途別(化学中毒、精神障害、騒音性難聴・振動、皮膚障害、慢性呼吸器疾患、じん肺、筋骨格系障害、がん、その他)、産業別(農林業、建設業、製造業、石油・鉱業、運輸業、その他) - 2027年までの世界の機会分析と産業予測


Occupational Medicines Market by Application (Chemical Poisoning, Psychological Disorder, Noise-Induced Hearing Loss & Vibration, Skin Disorder, Chronic Respiratory Disease, Pneumoconiosis, Musculoskeletal Disorder, Cancer, and Others), and Industry (Agriculture & Forestry, Construction, Manufacturing, Petroleum & Mining, Transportation, and Others) - Global Opportunity Analysis and Industry Forecast up to 2027

産業用医薬品市場とは、職場に関連した健康問題に対する医療サービスやソリューションの提供を中心とするヘルスケア産業のセグメントを指す。これには、業務に関連する怪我や病気の予防、診断、治療が含まれる。... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IHR Insights
アイエイチアールインサイト
2023年7月6日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
210 英語

 

サマリー

産業用医薬品市場とは、職場に関連した健康問題に対する医療サービスやソリューションの提供を中心とするヘルスケア産業のセグメントを指す。これには、業務に関連する怪我や病気の予防、診断、治療が含まれる。世界中の政府や規制機関が実施する厳しい労働安全衛生規制が、産業用医薬品の需要を押し上げている。雇用主は、適切な医療監視や予防措置を含め、従業員に安全で健康的な職場環境を提供することが求められている。このような規制を遵守するためには、労働災害を評価・管理するために産業用医薬品を使用する必要がある。一方、包括的な産業保健プログラムを実施するためのコストや、産業用医薬品に関する認識や教育の不足が、市場の成長を制限する可能性がある。産業用医薬品市場は、2027年までに年平均成長率6.6%で成長する可能性が高い。

産業用医薬品市場:用途別

化学中毒
精神障害
非誘発性難聴・振動
皮膚障害
慢性呼吸器疾患
じん肺
筋骨格系障害


産業別医薬品市場

農業・林業
建設業
製造業
石油・鉱業
運輸

地域別産業用医薬品市場

北米
欧州
アジア太平洋
その他の地域

用途別市場では、職業用医薬品市場は化学中毒、精神障害、非誘発性難聴・振動、皮膚障害、慢性呼吸器疾患、じん肺、筋骨格系障害、がんに区分される。このうち、慢性呼吸器疾患分野が市場で大きなシェアを占めると思われる。これは、世界中で喘息、慢性閉塞性肺疾患(COPD)、珪肺症などの呼吸器疾患が増加しているためである。作業関連の呼吸器疾患は、粉塵、ヒューム、ガスなど、肺を損傷する有害物質を吸い込むことによって引き起こされるいくつかの病気である。職業性肺疾患は呼吸困難に拍車をかけている。

職業用医薬品市場を牽引する主な要因は以下の通り:

労働安全衛生規制:世界中の政府や規制機関は、労働者の安全を確保するために厳しい労働安全衛生規制を実施している。これらの規制を遵守するためには、業務に関連した健康状態を予防・治療するための業務用医薬品の使用が必要となる。

高まる意識:健康な労働力を維持することの重要性について、雇用者の意識が高まっている。産業用医薬品は、従業員の健康を促進し、欠勤を減らし、生産性を向上させる上で重要な役割を果たしている。

職業病の発生率の上昇:呼吸器疾患、筋骨格系損傷、化学物質への暴露など、業務に関連する疾病は増加傾向にある。このため、これらの健康上の懸念に対応できる産業用医薬品に対する需要が生じている。

産業部門の拡大:さまざまな産業が拡大し続けるにつれ、職業上の危険にさらされる労働者の数も増加している。このことが、従業員の健康と安全を確保するための産業用医薬品の必要性をさらに高めている。

技術の進歩:医療技術の進歩により、革新的な診断ツール、治療法、職業病の予防法が開発されている。これが、産業用医薬品市場の成長に寄与している。

産業用医薬品市場の主な主要企業は、Amgen Inc.、AstraZeneca PLC、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Johnson & Johnson、Nestlé S.A. (Galderma S.A.)、Novartis AG、Pfizer Inc.、Sanofiである。

産業用医薬品市場には、健康診断、健康診断、予防接種、薬物検査、業務上の怪我や病気の治療など、様々な製品とサービスが含まれる。労働衛生に特化した医薬品と、労働衛生の専門家が提供する広範な医療サービスの両方が含まれる。

市場動向や力学は時間とともに変化する可能性があることに留意することが重要です。したがって、産業用医薬品市場の現状に関する最新情報を得るには、最近の市場調査報告書や業界刊行物を参照し、産業保健分野の関連ステークホルダーに接触することが望ましい。

世界の産業用医薬品市場の阻害要因、機会、課題、市場成長を促進する見込みを包括的に概観。
本レポートは、過去、現在、推定市場規模を数量と金額で示すとともに、詳細な市場セグメンテーションを提供します。
本レポートでは、現在の業界動向と発展、主要企業の競争展望と戦略、製品提供について紹介しています。
また、主要企業のSWOT分析、ポートフォリオ分析、能力分析も掲載しています。

ページTOPに戻る


目次

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Application: Market Size & Analysis
5.1. Chemical poisoning
5.2. Psychological disorder
5.3. Non-Induced hearing loss & vibration
5.4. Skin disorder
5.5. Chronic respiratory disease
5.6. Pneumoconiosis
5.7. Musculoskeletal disorder
5.8. Cancer
6. Industry: Market Size & Analysis
6.1. Agriculture & forestry
6.2. Construction
6.3. Manufacturing
6.4. Petroleum & mining
6.5. Transportation
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. ELI LILLY AND COMPANY.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. ASTRAZENECA PLC,
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Novartis AG
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. JOHNSON & JOHNSON.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. BRISTOL-MYERS SQUIBB COMPANY,
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.5.6. Business Strategy
9.6. F. HOFFMANN-LA ROCHE LTD
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. PFIZER IN
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Amgen Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. SANOFI.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Nestlé S.A
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

ページTOPに戻る



図表リスト

TABLE 1. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHEMICAL POISONING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PSYCHOLOGICAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR NON-INDUCED HEARING LOSS & VIBRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR SKIN DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHRONIC RESPIRATORY DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PNEUMOCONIOSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MUSCULOSKELETAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR AGRICULTURE & FORESTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CONSTRUCTION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MANUFACTURING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PETROLEUM & MINING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 19. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 20. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 21. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 23. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 24. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 25. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 26. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 27. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 28. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 29. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 30. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION 2021-2027 (USD BILLION)
TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY 2021-2027 (USD BILLION)
TABLE 32. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 33. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 34. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 35. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 36. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 37. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 38. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 39. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 40. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 41. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 42. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 43. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 44. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 46. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 47. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 48. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 49. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 50. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 51. SANOFI: FINANCIALS
TABLE 52. SANOFI: PRODUCTS & SERVICES
TABLE 53. SANOFI: RECENT DEVELOPMENTS
TABLE 54. PFIZER INC: FINANCIALS
TABLE 55. PFIZER INC: PRODUCTS & SERVICES
TABLE 56. PFIZER INC: RECENT DEVELOPMENTS
TABLE 57. ELI LILLY AND COMPANY: FINANCIALS
TABLE 58. ELI LILLY AND COMPANY: PRODUCTS & SERVICES
TABLE 59. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS
TABLE 60. NOVARTIS AG: FINANCIALS
TABLE 61. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 62. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 63. NESTLÉ S.A. (GALDERMA S.A.): FINANCIALS
TABLE 64. NESTLÉ S.A. (GALDERMA S.A.): PRODUCTS & SERVICES
TABLE 65. NESTLÉ S.A. (GALDERMA S.A.): RECENT DEVELOPMENTS
TABLE 66. ASTRAZENECA PLC: FINANCIALS
TABLE 67. ASTRAZENECA PLC: PRODUCTS & SERVICES
TABLE 68. ASTRAZENECA PLC: RECENT DEVELOPMENTS
TABLE 69. AMGEN INC.: FINANCIALS
TABLE 70. AMGEN INC: PRODUCTS & SERVICES
TABLE 71. AMGEN INC: RECENT DEVELOPMENTS
TABLE 72. F. HOFFMANN-LA ROCHE LTD: FINANCIALS
TABLE 73. F. HOFFMANN-LA ROCHE LTD: PRODUCTS & SERVICES
TABLE 74. F. HOFFMANN-LA ROCHE LTD: RECENT DEVELOPMENTS
TABLE 75. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
TABLE 76. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
TABLE 77. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
TABLE 78. JOHNSON & JOHNSON: FINANCIALS
TABLE 79. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 80. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS
TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES
TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS

 

ページTOPに戻る


 

Summary

The occupational medicines market refers to the segment of the healthcare industry that focuses on providing medical services and solutions for workplace-related health issues. This includes the prevention, diagnosis, and treatment of work-related injuries and illnesses. Stringent occupational health and safety regulations implemented by governments and regulatory bodies across the world drive the demand for occupational medicines. Employers are required to provide a safe and healthy work environment for their employees, including appropriate medical surveillance and preventive measures. Compliance with these regulations necessitates the use of occupational medicines to assess and manage occupational hazards. On the other hand, the cost of implementing comprehensive occupational health programs and lack of awareness and education on occupational medicines may limit the market growth. Occupational Medicines Market is likely to grow at a rate of 6.6% CAGR by 2027.

Occupational Medicines market by Application

Chemical poisoning
Psychological disorder
Non-Induced hearing loss & vibration
Skin disorder
Chronic respiratory disease
Pneumoconiosis
Musculoskeletal disorder
Cancer

Occupational Medicines market by Industry

Agriculture & forestry
Construction
Manufacturing
Petroleum & mining
Transportation

Occupational Medicines Market by Geography

North America
Europe
Asia Pacific
Rest of the World

In the market for application, the Occupational Medicines market is segmented into Chemical poisoning, Psychological disorder, Non-Induced hearing loss & vibration, Skin disorder, chronic respiratory disease, Pneumoconiosis, Musculoskeletal disorder and Cancer. Among them the chronic respiratory disease segment is likely to hold the significant share in the market. This is accredited to the rising number of respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and silicosis across the world. Work-related respiratory diseases are several illnesses caused by breathing in hazardous substances that damage the lungs, such as dust, fumes, and gases. Occupational lung disease has been adding to respiratory distress.

Key factors driving the occupational medicines market include:

Occupational Health and Safety Regulations: Governments and regulatory bodies across the world have implemented stringent occupational health and safety regulations to ensure worker safety. Compliance with these regulations necessitates the use of occupational medicines to prevent and treat work-related health conditions.

Growing Awareness: There is an increasing awareness among employers about the importance of maintaining a healthy workforce. Occupational medicines play a crucial role in promoting employee well-being, reducing absenteeism, and improving productivity.

Rising Incidence of Occupational Diseases: Work-related illnesses, such as respiratory disorders, musculoskeletal injuries, and chemical exposures, are on the rise. This has created a demand for occupational medicines that can address these specific health concerns.

Expansion of Industrial Sectors: As various industries continue to expand, the number of workers exposed to occupational hazards also increases. This further drives the need for occupational medicines to ensure employee health and safety.

Technological Advancements: Advancements in medical technology have led to the development of innovative diagnostic tools, treatments, and preventive measures for occupational diseases. This has contributed to the growth of the occupational medicines market.

The major leading companies of the Occupational Medicines market are Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Nestlé S.A. (Galderma S.A.), Novartis AG, Pfizer Inc., Sanofi.

The market for occupational medicines includes various products and services, such as medical examinations, health screenings, vaccinations, drug testing, and treatment of work-related injuries and illnesses. It encompasses both pharmaceutical products specific to occupational health and broader medical services provided by occupational health professionals.

It's important to note that market trends and dynamics can change over time. Therefore, for the most up-to-date information on the current state of the occupational medicines market, it is advisable to consult recent market research reports, industry publications, and reach out to relevant stakeholders in the occupational health sector.

Comprehensive overview of the global Occupational Medicines market restrains, opportunities, challenges, expected to drive its market growth.
The report provides the in-depth market segmentation along with the past, present and estimated market size in terms of volume and value.
This report presents the current industry trends and developments and the competitive outlook and strategies of key players and product offerings.
This report also depicts the SWOT analysis, portfolio analysis, capability analysis of the leading competitors.



ページTOPに戻る


Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Application: Market Size & Analysis
5.1. Chemical poisoning
5.2. Psychological disorder
5.3. Non-Induced hearing loss & vibration
5.4. Skin disorder
5.5. Chronic respiratory disease
5.6. Pneumoconiosis
5.7. Musculoskeletal disorder
5.8. Cancer
6. Industry: Market Size & Analysis
6.1. Agriculture & forestry
6.2. Construction
6.3. Manufacturing
6.4. Petroleum & mining
6.5. Transportation
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. ELI LILLY AND COMPANY.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. ASTRAZENECA PLC,
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. Novartis AG
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. JOHNSON & JOHNSON.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. BRISTOL-MYERS SQUIBB COMPANY,
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.5.6. Business Strategy
9.6. F. HOFFMANN-LA ROCHE LTD
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. PFIZER IN
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Amgen Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. SANOFI.
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Nestlé S.A
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

ページTOPに戻る



List of Tables/Graphs

TABLE 1. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHEMICAL POISONING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PSYCHOLOGICAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR NON-INDUCED HEARING LOSS & VIBRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR SKIN DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHRONIC RESPIRATORY DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PNEUMOCONIOSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MUSCULOSKELETAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR AGRICULTURE & FORESTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CONSTRUCTION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MANUFACTURING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PETROLEUM & MINING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 19. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 20. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 21. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 23. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 24. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 25. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 26. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 27. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 28. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 29. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 30. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION 2021-2027 (USD BILLION)
TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY 2021-2027 (USD BILLION)
TABLE 32. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 33. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 34. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 35. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 36. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 37. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 38. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 39. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 40. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 41. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 42. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 43. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 44. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 46. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 47. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 48. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 49. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 50. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION)
TABLE 51. SANOFI: FINANCIALS
TABLE 52. SANOFI: PRODUCTS & SERVICES
TABLE 53. SANOFI: RECENT DEVELOPMENTS
TABLE 54. PFIZER INC: FINANCIALS
TABLE 55. PFIZER INC: PRODUCTS & SERVICES
TABLE 56. PFIZER INC: RECENT DEVELOPMENTS
TABLE 57. ELI LILLY AND COMPANY: FINANCIALS
TABLE 58. ELI LILLY AND COMPANY: PRODUCTS & SERVICES
TABLE 59. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS
TABLE 60. NOVARTIS AG: FINANCIALS
TABLE 61. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 62. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 63. NESTLÉ S.A. (GALDERMA S.A.): FINANCIALS
TABLE 64. NESTLÉ S.A. (GALDERMA S.A.): PRODUCTS & SERVICES
TABLE 65. NESTLÉ S.A. (GALDERMA S.A.): RECENT DEVELOPMENTS
TABLE 66. ASTRAZENECA PLC: FINANCIALS
TABLE 67. ASTRAZENECA PLC: PRODUCTS & SERVICES
TABLE 68. ASTRAZENECA PLC: RECENT DEVELOPMENTS
TABLE 69. AMGEN INC.: FINANCIALS
TABLE 70. AMGEN INC: PRODUCTS & SERVICES
TABLE 71. AMGEN INC: RECENT DEVELOPMENTS
TABLE 72. F. HOFFMANN-LA ROCHE LTD: FINANCIALS
TABLE 73. F. HOFFMANN-LA ROCHE LTD: PRODUCTS & SERVICES
TABLE 74. F. HOFFMANN-LA ROCHE LTD: RECENT DEVELOPMENTS
TABLE 75. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS
TABLE 76. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES
TABLE 77. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS
TABLE 78. JOHNSON & JOHNSON: FINANCIALS
TABLE 79. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 80. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS
TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES
TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

IHR Insights社の医療分野での最新刊レポート


よくあるご質問


IHR Insights社はどのような調査会社ですか?


IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る